(1 - 8 von 9
)
Gracell Bio leverages Lonza's expertise in CAR-T cell therapy...
www.biospectrumasia.com
Gracell Biotechnologies signs agreement with Lonza to manufacture Gracell's FasTCAR product candidates in the U.S.
Gracell Biotechnologies to Participate in the Virtual Wells...
www.einnews.com
· Management participants: Dr. William (Wei) Cao, Founder and CEO; Dr. Martina Sersch, M.D., CMO; Dr. Kevin Xie, CFO.
Gracell Biotechnologies to Pre - GuruFocus.com
www.gurufocus.com
· ... with our dual-targeting CAR-T therapy, including in high risk patients," said Dr. Martina Sersch, MD, Chief Medical Officer of Gracell.
People on the Move | | FDAnewswww.fdanews.com › articles › people-on-th...
www.fdanews.com
· Gracell Biotechnologies has appointed Martina Sersch as chief medical officer. Sersch is currently the CMO of Mustang Bio.
sortiert nach Relevanz / Datum